Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.17% | -62.21% | 190.47% | -93.40% | -136.85% |
| Total Depreciation and Amortization | 95.88% | 113.87% | 175.94% | 37.32% | 25.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 167.82% | 697.18% | -1,643.21% | 1,497.68% | 158.42% |
| Change in Net Operating Assets | -895.10% | 1,299.24% | -17,471.72% | -30.58% | 251.57% |
| Cash from Operations | -120.16% | 129.17% | -76.64% | -158.92% | -106.71% |
| Capital Expenditure | 118.10% | -276.43% | -9,250.00% | -129.49% | 45.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.42% | -1,543.40% | 58.04% | 71.91% | 124.09% |
| Cash from Investing | 52.22% | -1,560.19% | 68.93% | 73.91% | 123.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 303.29% | -9.95% | 114,735.28% | 14,367.25% | -99.90% |
| Repurchase of Common Stock | -- | -1,550.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 33.28% | -- |
| Cash from Financing | 303.29% | -315.33% | 114,532.03% | 7,524.44% | -99.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -753.70% | -2,680.55% | 26,692.02% | 78.94% | -101.80% |